11-13 November 2025
Congress Center BaselBasel, Switzerland Steven StantonSenior Scientist in Oligonucleotide Process Chemistry at AstraZenecaSpeaker
Profile
Dr Steven Stanton joined AstraZeneca in 2021 as a Senior Scientist in Process Chemistry at the Macclesfield site in the UK. Since then he has focussed on the optimisation of solid-phase oligonucleotide synthesis for AstraZeneca's late stage oligonucleotide platform including through the application of PAT technologies. Prior to AstraZeneca, Steven obtained his PhD in small molecule organic chemistry from the University of Bristol in the UK, and carried out a post-doc in mRNA delivery materials at Stanford University, USA.
Agenda Sessions
Optimization of the Solid-phase Oligonucleotide Detritylation Reaction Using In-line IR PAT
, 09:05View Session